Overview of the OPDC Cohort day
Short video highlighting the key research that was being discussed during the OPDC Cohorts day
Alph-Synuclein - What's it all about?
enJuly 05, 2016
What was the main topic of the podcast episode?
Summarise the key points discussed in the episode?
Were there any notable quotes or insights from the speakers?
Which popular books were mentioned in this episode?
Were there any points particularly controversial or thought-provoking discussed in the episode?
Were any current events or trending topics addressed in the episode?
About this Episode
Dr Claudio Ruffman discusses his research into the protein, Alpha-Synuclein, which is crucial in the pathogenesis of Parkinson's
Recent Episodes from OPDC: Progress in Parkinson's Research.
What Should the Cohort Studies Delivery for YOU
Dr Michele Hu discusses what Clinicians would like before asking the cohort members what they would like.
Introduction to the OPDC Cohort Day 2016
Dr Michele Hu gives a brief introduction to the Cohort members, outlining the programme for the day.
Drug and Target Discovery in Parkinson's Disease
Prof. Richard Wade-Martins discusses how you pick promising new drugs targets for Parkinson's
Alph-Synuclein - What's it all about?
Dr Claudio Ruffman discusses his research into the protein, Alpha-Synuclein, which is crucial in the pathogenesis of Parkinson's
Does Sleep Matter in Parkinson's
Dr Tom Barber discusses his research
Personality and Impulsivity in Parkinson's
Dr Fahd Baig discusses his latest research in personality disorders and impulsivity with those affected with Parkinson's
How can skin cells help us understand Parkinson's?
Richard Wade Martins, OPDC Principal Investigator, discusses his current research into Skin cells and Stem cells
Overview: The Oxford Parkinson's Disease Centre (OPDC) Cohort
Michele Hu, co-Principle Investigator of the OPDC, gives an overview of the Centre's vision and research themes
From Dreams to Neurodegeneration
REM sleep behaviour disorder and Parkinson's Disease